Psychotherapeutic intervention for suicide attempters: A randomized controlled study

• Register: ANZCTR
• Last refreshed on: 13 January 2020
• Main ID: ACTRN12605000743662
• Date of registration: 15/11/2005
• Prospective Registration: Yes
• Primary sponsor: Australian Institute for Suicide Research and Prevention, Griffith University
• Public title: Psychotherapeutic intervention for suicide attempters: A randomized controlled study
• Scientific title: A randomized controlled study to evaluate the efficacy of modified dialectic behaviour therapy in preventing repetition of suicidal behaviour in individuals who have attempted suicide
• Date of first enrolment: 15/03/2006
• Target sample size: 100
• Recruitment status: Not yet recruiting
• URL: https://anzctr.org.au/ACTRN12605000743662.aspx
• Study type: Interventional
• Study design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;

Countries of recruitment

Australia

Contacts

• Name: Professor Diego De Leo

• Name: Dr Karolina Krysinska

Key inclusion & exclusion criteria

Inclusion criteria: (a) suicide attempt within the last 14 days, (b) diagnosis: affective disorder, anxiety disorder, personality disorder, no diagnosis.
Exclusion criteria: (a) current acute suicidality, (b) diagnosis: acute psychosis, intellectual impairment, substance abuse disorder, permanent physical disability.

Age minimum: Not stated
Age maximum: Not stated
Gender: Both males and females

Health Condition(s) or Problem(s) studied

Mental Health - Suicide

Suicide attempts;
Suicide attempts

Intervention(s)

Modified version of dialectic bahaviour therapy not inclusive of group supervision (16 sessions, subject to continuation if needed).
Study participants will be followed-up over the period of 24 months and the recruitment into study is planned for six months.

Primary Outcome(s)

Reduced rate of repetition of suicidal behaviour[Over the follow-up period of 24 months.]

Secondary Outcome(s)

Remission in suicidal ideation, hopelessness, depression, anxiety and impulsiveness, and improved quality of life.[Over the 24-months follow-up period.]

Source(s) of Monetary Support

Australian Institute for Suicide Research and Prevention, Griffith University

Secondary Sponsor(s)

In-kind contribution from Princess Alexandra Hospital Brisbane

University of Queensland

Ethics review

Status: Not approved
Approval date:
Contact:

Griffith University Human Research Ethics Committee

Status: Not approved
Approval date:
Contact:

Princess Alexandra Hospital Human Research Ethics Committee